A cross-border alliance of health technology assessment (HTA) agencies has been announced by the Can...
Read moreOur research is aimed at identifying trends in terminated appraisals in relation to therapeutic area...
Read moreWe analyse subscription-based agreements for antibiotics in Europe to understand how it may address ...
Read moreIdentifying EAPs and understanding the opportunities that would best complement manufacturer pricing...
Read moreLeem report the changes set out by the Government will heighten the difficulties already being faced...
Read moreThe short answer to the question “how important is HTA when launching a biosimilar in the EU5?” ...
Read moreStudy designs that combine explanatory and pragmatic aspects have recently been weighted up by autho...
Read moreOn 28th September there was a two-hour public hearing on the GKV Financial Stabilisation Act. There ...
Read moreWe investigate Single Technology Appraisals (STAs) conducted by NICE, comparing outcomes for monothe...
Read moreWe look at whether payers are willing to pay for innovative gene therapies & CAR-Ts and the impact o...
Read more